Related Experiment Video
Updated: Nov 4, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Endothelial Dysfunction for Acute Kidney Injury in Coronavirus Disease 2019: How Concerned Should We Be?
Yung-Chang Chen1,2, Ji-Tseng Fang1,2, Chih-Wei Yang1,2
1Department of Nephrology, Kidney Research Center, Taipei, Taiwan.
Insights
Critically ill COVID-19 patients who develop acute kidney injury requiring kidney replacement therapy face a high mortality risk. Predictors include higher BMI, CKD stage, and lower oxygenation levels upon ICU admission.
Area of Science:
- Nephrology
- Critical Care Medicine
- Infectious Diseases
Background:
- Coronavirus disease 2019 (COVID-19) pandemic presents significant challenges in critical care.
- Kidney dysfunction, particularly acute kidney injury (AKI), is a frequent complication in severe COVID-19.
- AKI in COVID-19 patients is associated with substantially worse clinical outcomes and increased mortality.
Purpose of the Study:
- To investigate the incidence and predictors of AKI requiring kidney replacement therapy (KRT) in critically ill COVID-19 patients.
- To identify factors associated with mortality in COVID-19 patients who develop AKI-KRT.
- To analyze the relationship between patient characteristics, disease severity, and AKI development in the context of COVID-19.
Main Methods:
- Multicenter retrospective observational study (STOP-COVID).
- Enrolled 3,099 critically ill adult COVID-19 patients admitted to intensive care units (ICUs).
- Analyzed data on AKI development, need for KRT, and 28-day mortality, alongside patient demographics and clinical parameters.
Main Results:
- 20.6% of patients developed AKI requiring KRT (AKI-KRT) within 14 days of ICU admission.
- Mortality within 28 days of ICU admission was 54.9% among patients with AKI-KRT.
- Predictors for AKI-KRT included higher BMI, advanced chronic kidney disease (CKD) stages, lower PaO2:FiO2 ratio, and increased vasopressor use on ICU admission.
Conclusions:
- Critically ill COVID-19 patients developing AKI requiring KRT have a very high mortality rate.
- Patient factors like obesity and pre-existing kidney disease, along with acute illness severity (hypoxia, vasopressor need), are key predictors of AKI-KRT.
- These findings highlight the critical role of kidney function monitoring and management in severe COVID-19 care.
Context:
The outbreak of coronavirus disease 2019 (CO-VID-19) has rapidly evolved into a global pandemic. Kidney dysfunction is common among patients with COVID-19, and patients who develop acute kidney injury (AKI) have inferior outcomes. There is a growing body of evidence that AKI occurs in a substantial number of patients with COVID-19 and that developing AKI is associated with significantly worse outcomes for COVID-19 patients. The risk for death was amplified when AKI resulted in kidney replacement therapy (KRT). Subject of Review: The Study of the Treatment and Outcomes in Critically Ill Patients with COVID-19 (STOP-COVID) conducted a multicenter retrospective observational study enrolling 3,099 critically ill adults with COVID-19 admitted to intensive care units (ICUs) (J Am Soc Nephrol 2021;32:161-176). A total of 637 of 3,099 patients (20.6%) developed AKI treated with KRT (AKI-KRT) within 14 days of ICU admission, 350 of whom (54.9%) died within 28 days of ICU admission. Predictors of COVID-19 patients' progress to AKI-KRT were higher BMI, higher stages of CKD, lower ratio of the partial pressure of arterial oxygen over the fraction of inspired oxygen (PaO2:FiO2 ratio) on ICU admission, and greater number of vasopressors received on ICU admission. Second Opinion: Recently, some investigations revealed that the independent predictors of COVID-19 with AKI include older age, Black race, diabetes, hypertension, cardiovascular disease, mechanical ventilation, higher interleukin-6 level, and use of vasopressor medications. It seems that the underlying comorbidities with preexisting vascular endothelial damage and/or the more serious critically ill CO-VID-19 patients can contribute to the development of AKI and even AKI-KRT.
More Related Videos
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury V: Interprofessional Care

